相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted Lu-177-Radionuclide Tumor Therapy in Mice
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β--Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours
Jaap J. M. Teunissen et al.
ENDOCRINE-RELATED CANCER (2011)
The low-energy β- and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy
Silvia Lehenberger et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
Edgar J. Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Target burn-up corrected specific activity of Lu-177 produced via Lu-176(n, gamma) Lu-177 nuclear reactions
K. P. Zhernosekov et al.
APPLIED RADIATION AND ISOTOPES (2008)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate
Joseph A. Reddy et al.
CANCER RESEARCH (2007)
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals
F. Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Dosimetric characterization of radionuclides for systemic tumor therapy:: Influence of particle range, photon emission, and subcellular distribution
Helena Uusijarvi et al.
MEDICAL PHYSICS (2006)
Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3] octreotate
JJM Teunissen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Production logistics of 177Lu for radionuclide therapy
MRA Pillai et al.
APPLIED RADIATION AND ISOTOPES (2003)
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate
DJ Kwekkeboom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide
J Sancéau et al.
ONCOGENE (2002)
Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors
P Bernhardt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
End-stage renal disease after treatment with 90Y-DOTATOC
M Cybulla et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Radiochemical separation of no-carrier-added Lu-177 as produced via the Yb-176(n,gamma)Yb-177 -> Lu-177 process
NA Lebedev et al.
APPLIED RADIATION AND ISOTOPES (2000)
分享论文
